J&J: FDA green light for MemoryGel breast implants
(CercleFinance.com) - J&J announces that Mentor Worldwide LLC, the world's leading brand in breast aesthetics and a subsidiary of Johnson & Johnson MedTech, has received FDA approval for its MemoryGel Enhance breast implants for primary and secondary post-mastectomy reconstruction in women.
These silicone implants - ranging from 930 cc to 1445 cc - offer unprecedented options for patients requiring larger volumes, responding to a long-neglected demand.
Their commercial launch is scheduled for mid-2025 in the US.
Supported by the three-year results of the ATHENA study, this breakthrough aims to improve aesthetic results and meet the diverse expectations of breast reconstruction patients.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
These silicone implants - ranging from 930 cc to 1445 cc - offer unprecedented options for patients requiring larger volumes, responding to a long-neglected demand.
Their commercial launch is scheduled for mid-2025 in the US.
Supported by the three-year results of the ATHENA study, this breakthrough aims to improve aesthetic results and meet the diverse expectations of breast reconstruction patients.
Copyright (c) 2024 CercleFinance.com. All rights reserved.